Enovix (NASDAQ:ENVX) Shares Up 6.9% – Should You Buy?

Enovix Corporation (NASDAQ:ENVX)’s share price rose 6.9% on Wednesday. The company traded as high as $2.39 and last traded at $2.4050. 1,949,566 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 6,821,366 shares. The stock had previously closed at $2.25.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on ENVX shares. William Blair cut shares of Enovix from an “outperform” rating to a “market perform” rating in a research report on Monday, August 17th. Northland Securities set a $5.00 price objective on Enovix in a research report on Tuesday, October 13th. Bank of America reissued a “neutral” rating and issued a $5.00 target price on shares of Enovix in a research note on Monday, August 17th. Cantor Fitzgerald restated an “overweight” rating and set a $25.00 target price on shares of Enovix in a research report on Thursday, August 13th. Finally, Craig Hallum set a $7.00 price target on Enovix in a research note on Thursday, August 13th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Enovix presently has a consensus rating of “Moderate Buy” and an average price target of $10.77.

Enovix Stock Performance

The company has a quick ratio of 9.37, a current ratio of 9.71 and a debt-to-equity ratio of 2.46. The stock’s fifty day moving average is $3.08 and its 200-day moving average is $4.98. The stock has a market cap of $545.33 million, a price-to-earnings ratio of -3.08 and a beta of 2.49.

Enovix (NASDAQ:ENVX) last posted its earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.02. The firm had revenue of $9.02 million for the quarter, compared to analyst estimates of $8.43 million. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%. The company’s revenue for the quarter was up 20.8% on a year-over-year basis. During the same period in the previous year, the company posted ($0.13) earnings per share. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. On average, analysts forecast that Enovix Corporation will post -0.79 EPS for the current year.

Institutional Trading of Enovix

A number of large investors have recently bought and sold shares of ENVX. BlackRock Inc. bought a new position in Enovix in the second quarter valued at approximately $100,054,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Enovix during the second quarter worth $8,689,000. Bank of America Corp DE acquired a new stake in shares of Enovix during the second quarter worth $8,356,000. Bank of New York Mellon Corp acquired a new stake in shares of Enovix during the second quarter worth $3,551,000. Finally, Deutsche Bank AG bought a new stake in Enovix in the 2nd quarter valued at $3,343,000. 50.92% of the stock is owned by institutional investors.

Enovix Company Profile

Enovix Corporation is a battery technology company developing lithium-ion batteries that use a silicon-based anode and a three-dimensional cell architecture. The company’s design is intended to increase energy density while incorporating structural features designed to improve safety and cycle life compared with conventional lithium-ion batteries.

Enovix is focused initially on batteries for consumer electronics, including smartphones, wearable devices and other mobile products. It has also identified applications in industrial, medical, aerospace, defense and electric vehicle markets.